Galderma Group AG (GALDY)

OTCMKTS · Delayed Price · Currency is USD
23.91
+0.69 (2.97%)
May 16, 2025, 4:00 PM EDT
43.60%
Market Cap 28.63B
Revenue (ttm) 4.44B
Net Income (ttm) 231.00M
Shares Out n/a
EPS (ttm) 0.97
PE Ratio 123.96
Forward PE 40.64
Dividend 0.02 (0.10%)
Ex-Dividend Date Apr 28, 2025
Volume 2,238
Average Volume 7,547
Open 24.33
Previous Close 23.22
Day's Range 23.82 - 24.50
52-Week Range 15.51 - 27.20
Beta n/a
RSI 62.99
Earnings Date Jul 24, 2025

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic ... [Read more]

Industry Pharmaceutical Preparations
Founded 1981
Employees 6,545
Stock Exchange OTCMKTS
Ticker Symbol GALDY
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.